Case Investigations

Longfin Corp.

April 3, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Longfin Corp. (“Longfin” or the “Company”) (NASDAQ: LFIN) concerning potential securities law violations.  Investors who purchased Longfin securities in the Company’s December 2017 initial public offering (the “IPO”) or since the IPO may be affected.

L'Oreal

March 29, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of consumers of L’Oréal and Maybelline Cosmetic products.

Micro Focus International plc

March 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Micro focus International plc (“Micro Focus” or the “Company”) (NYSE: MFGP), including purchasers of Micro Focus American Depositary Receipts (“ADRs”).

BRF S.A.

March 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of BRF S.A. (“BRF” or the “Company”) (NYSE:  BRFS).

VelocityShares Daily Inverse VIX Short Term ETNs

March 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Credit Suisse VelocityShares Daily Inverse VIX Short Term ETNs (NASDAQ: XIV).

Acadia Healthcare Company, Inc.

March 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. (“Acadia Healthcare” or the “Company”) (NASDAQ:  ACHC).

Foot Locker, Inc.

March 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Foot Locker, Inc. (“Foot Locker” or the “Company”) (NYSE: FL).

Facebook, Inc.

March 19, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Facebook Inc.  (“Facebook” or the “Company”) (NASDAQ: FB) concerning potential securities law violations.  Investors who purchased Facebook securities may be affected.

TrueCar, Inc.

March 16, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigating of potential claims on behalf of investors of TrueCar, Inc. (“TrueCar” or the “Company”) (NASDAQ:  TRUE) for violations of the federal securities laws.  Investors who purchased TrueCar common stock may be affected.

AutoWeb, Inc.

March 12, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of AutoWeb, Inc. (“AutoWeb or the “Company”) (NASDAQ: AUTO), formerly Autobytel, Inc.  Investors who purchased AutoWeb common stock may be affected.

WageWorks, Inc.

March 9, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating San Mateo, California-based WageWorks, Inc. (“WageWorks” or the “Company”) (NYSE: WAGE) concerning potential violations of the federal securities laws.

Akorn, Inc.

February 27, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ: AKRX), a specialty generic pharmaceutical company, concerning potential securities law violations.  Investors who purchased Akorn securities may be affected.

Aflac Incorporated

February 26, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Aflac Incorporated (“Aflac” or the “Company”) (NYSE: AFL).  Investors who purchased Aflac common stock between February 27, 2013 and January 11, 2018, inclusive (the “Class Period”), may be affected.

Synergy Pharmaceuticals Inc.

February 23, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Synergy Pharmaceuticals Inc. (“Synergy” or the “Company”) (NASDAQ: SGYP).  Investors who purchased Synergy securities between September 5, 2017 and November 14, 2017, inclusive (the “Class Period”), may be affected.

Super Micro Computer, Inc.

February 23, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NASDAQ: SMCI).  Investors who purchased Super Micro securities between August 5, 2016 and January 30, 2018, inclusive (the “Class Period”), may be affected.

MiMedx Group, Inc.

February 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating MiMedx Group, Inc. (“MiMedx” or the “Company”) (NASDAQ: MDXG), a developer and marketer of regenerative and therapeutic biologics, concerning potential securities law violations.  Investors who purchased MiMedx shares may be affected.

Ubiquiti Networks, Inc.

February 20, 2018 – Kaplan Fox Announces Investigation of Ubiquiti Networks, Inc.

Quantum Corporation

February 12, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Quantum Corporation (“Quantum” or the “Company”) (NYSE: QTM).  Investors who purchased shares of Quantum common stock may be affected.

TrueCar, Inc.

February 7, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of TrueCar, Inc. (“TrueCar” or the “Company”) (NASDAQ:  TRUE).  Investors who purchased TrueCar common stock may be affected.

MetLife, Inc.

January 31, 2018 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating MetLife, Inc. (“MetLife” or the “Company”) (NYSE: MET) on behalf of investors who purchased MetLife securities.

Obalon Therapeutics, Inc.

January 24, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:  OBLN).  Investors who purchased Obalon common stock may be affected.

Aerohive Networks, Inc.

January 24, 2018 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Aerohive Networks, Inc. (“Aerohive” or the “Company”) (Nasdaq: HIVE) on behalf of investors who purchased Aerohive securities.

GoPro, Inc.

January 17, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of GoPro, Inc. (“GoPro” or the “Company”) (NASDAQ: GPRO).  Investors who purchased GoPro securities between August 4, 2017 and January 5, 2018, inclusive (the “Class Period”) may be affected.

AZZ, Inc.

January 10, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of AZZ Inc. (“AZZ” or the “Company”) (NYSE: AZZ).  Investors who purchased shares of AZZ securities may be affected.

Capitala Finance Corp.

January 9, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Capitala Finance Corp. (“Capitala ” or the “Company”) (NASDAQ: CPTA).  Investors who purchased Capitala shares may be affected.

The Crypto Company

January 9, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Crypto Company (“Crypto” or the “Company”) (OTC: CRCW).  Crypto is a technology company that operates in the digital currencies and blockchain sector.  The Company offers a portfolio of digital assets, technologies, and consulting services to the blockchain and cryptocurrency markets.  Investors who purchased Crypto common shares may be affected.

Liberty Tax, Inc.

December 12, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Liberty Tax, Inc. (“Liberty Tax” or the “Company”) (NASDAQ: TAX).  Investors who purchased shares of Liberty Tax securities may be affected.

Omega Healthcare Investors, Inc.

November 29, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Omega Healthcare Investors, Inc. (“Omega Healthcare” or the “Company”) (NYSE: OHI), a real estate investment trust (REIT) that invests in income producing healthcare facilities.  Investors who purchased Omega Healthcare common stock may be affected.

Triangle Capital Corporation

November 16, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Triangle Capital Corporation ("Triangle Capital" or the "Company") (NYSE: TCAP).  Investors who purchased Triangle Capital common stock may be affected.

Acorda Therapeutics, Inc.

November 15, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Envision Healthcare Corporation (“Envision Healthcare” or the “Company”) (NYSE: EVHC).